HealthEquity Cash on Hand 2014-2024 | HQY

HealthEquity cash on hand from 2014 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • HealthEquity cash on hand for the quarter ending April 30, 2024 was $0.251B, a 11.34% increase year-over-year.
  • HealthEquity cash on hand for 2024 was $0.404B, a 58.88% increase from 2023.
  • HealthEquity cash on hand for 2023 was $0.254B, a 12.8% increase from 2022.
  • HealthEquity cash on hand for 2022 was $0.225B, a 31.44% decline from 2021.
HealthEquity Annual Cash on Hand
(Millions of US $)
2024 $404
2023 $254
2022 $225
2021 $329
2020 $192
2019 $361
2018 $240
2017 $180
2016 $124
2015 $111
2014 $14
2013 $7
HealthEquity Quarterly Cash on Hand
(Millions of US $)
2024-04-30 $251
2024-01-31 $404
2023-10-31 $334
2023-07-31 $290
2023-04-30 $226
2023-01-31 $254
2022-10-31 $210
2022-07-31 $177
2022-04-30 $161
2022-01-31 $225
2021-10-31 $649
2021-07-31 $754
2021-04-30 $737
2021-01-31 $329
2020-10-31 $299
2020-07-31 $269
2020-04-30 $171
2020-01-31 $192
2019-10-31 $175
2019-07-31 $815
2019-04-30 $329
2019-01-31 $361
2018-10-31 $330
2018-07-31 $303
2018-04-30 $270
2018-01-31 $240
2017-10-31 $225
2017-07-31 $210
2017-04-30 $196
2017-01-31 $180
2016-10-31 $166
2016-07-31 $149
2016-04-30 $133
2016-01-31 $124
2015-10-31 $125
2015-07-31 $149
2015-04-30 $115
2015-01-31 $111
2014-10-31 $108
2014-07-31 $21
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-01-31 $7
Sector Industry Market Cap Revenue
Medical Medical Services $7.157B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.295B 15.60
Cencora (COR) United States $47.007B 18.33
ICON (ICLR) Ireland $26.068B 24.61
DiDi Global (DIDIY) China $21.483B 0.00
Avantor (AVTR) United States $14.638B 21.55
CochLear (CHEOY) Australia $14.016B 0.00
Revvity (RVTY) United States $13.265B 23.27
Natera (NTRA) United States $13.164B 0.00
Medpace Holdings (MEDP) United States $12.413B 40.84
Viatris (VTRS) United States $12.216B 3.65
EUROFINS SCIENT (ERFSF) Luxembourg $10.939B 0.00
Charles River Laboratories (CRL) United States $10.798B 20.67
Solventum (SOLV) United States $9.292B 0.00
Sonic Healthcare (SKHHY) Australia $8.560B 0.00
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.259B 4.99
Doximity (DOCS) United States $5.034B 35.26
PACS (PACS) United States $4.404B 0.00
Life Times (LTH) United States $3.653B 38.27
Sotera Health (SHC) United States $3.278B 16.08
Surgery Partners (SGRY) United States $3.011B 27.55
GoodRx Holdings (GDRX) United States $2.927B 111.43
Agilon Health (AGL) United States $2.612B 0.00
Progyny (PGNY) United States $2.413B 41.54
NovoCure (NVCR) Jersey $2.063B 0.00
AMN Healthcare Services Inc (AMN) United States $2.019B 8.00
Premier (PINC) United States $1.914B 8.19
BrightSpring Health Services (BTSG) United States $1.785B 0.00
Teladoc Health (TDOC) United States $1.637B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.356B 0.00
Establishment Labs Holdings (ESTA) $1.176B 0.00
CareDx (CDNA) United States $0.728B 0.00
Embecta (EMBC) United States $0.719B 4.89
GeneDx Holdings (WGS) United States $0.703B 0.00
Pediatrix Medical (MD) United States $0.649B 6.88
InnovAge Holding (INNV) United States $0.619B 0.00
Auna S.A (AUNA) Luxembourg $0.594B 0.00
Enhabit (EHAB) United States $0.442B 44.05
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.432B 0.00
ModivCare (MODV) United States $0.370B 6.93
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.313B 17.11
LifeMD (LFMD) United States $0.300B 0.00
Sharecare (SHCR) United States $0.281B 0.00
MultiPlan (MPLN) United States $0.247B 0.00
Sera Prognostics (SERA) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.219B 0.00
Ascend Wellness Holdings (AAWH) United States $0.189B 0.00
Biodesix (BDSX) United States $0.185B 0.00
So-Young (SY) China $0.111B 53.55
Pono Capital Two (PTWO) United States $0.071B 0.00
Co-Diagnostics (CODX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.043B 5.83
IceCure Medical (ICCM) Israel $0.034B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.028B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.024B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
KindlyMD (KDLY) $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.016B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.001B 0.00